The Frontal QRS-T Angle Remains Unchanged in Patients Without Structural Heart Disease Receiving Flecainide Therapy
Open Access
- 14 April 2026
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 167
Abstract
Introduction: Prolongation of the QT interval and QRS duration, which are markers of ventricular repolarization and depolarization, has been reported in patients receiving flecainide therapy. However, the effects of flecainide on the QRS–T angle—a recognized indicator of transmural dispersion of repolarization—remain unclear. The aim of our study was to investigate the impact of flecainide therapy on the QRS–T angle. Method: In this study, 200 patients who were prescribed flecainide therapy due to atrial or ventricular arrhythmias were included. Prior to the initiation of flecainide treatment, all patients underwent a 12-lead electrocardiogram (ECG) in which heart rate (HR), PR and QRS durations, QT, QTc, JT, Tp–Te intervals and the frontal plane QRS–T angle were measured. At the 1-month follow-up, patients underwent repeat ECG recording and were evaluated for both cardiac and non-cardiac side effects of flecainide. The same ECG parameters were measured again using the follow-up recordings. Changes in ECG parameters between the baseline and 1-month post-treatment were analyzed. Results: Following flecainide administration, the drug was discontinued in 18 patients (9%) due to adverse effects (11 cases of cardiac and seven cases of non-cardiac). HR significantly decreased (78 ± 22 bpm to 74 ± 15 bpm and p < 0.05). PR interval and QRS duration significantly increased (148 ± 23 ms to 156 ± 9 ms and 89 ± 17 ms to 99 ± 19 ms, respectively p < 0.05 for each). Additionally, JT interval (326 ± 27 ms vs. 334 ± 6 ms), QT interval (416 ± 24 ms vs. 434 ± 24 ms), QTc interval (431 ± 24 vs. 447 ± 25 ms) and Tp–Te interval (84 ± 17 vs. 87 ± 18 ms) all showed statistically significant increases after flecainide treatment (p < 0.05 for-each). However, no significant change was observed in the frontal QRS–T angle. Discussion: In patients receiving flecainide therapy for atrial and ventricular arrhythmias, prolongation was observed in atrioventricular conduction, ventricular depolarization and repolarization parameters as measured by ECG. However, no significant change was detected in the frontal QRS–T angle.Keywords
This publication has 33 references indexed in Scilit:
- Spatial QRS-T angle can indicate presence of myocardial fibrosis in pediatric and young adult patients with hypertrophic cardiomyopathyJournal of Electrocardiology, 2024
- QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohortsDiabetologia, 2024
- Prognostic significance of QRS distortion and frontal QRS-T angle in patients with ST-elevation myocardial infarctionInternational Journal of Cardiology, 2021
- 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathHeart Rhythm, 2018
- Electrocardiographic Predictors of Morbidity and Mortality in Patients With Acute Myocarditis: The Importance of QRS-T AngleJournal of Cardiac Failure, 2018
- A large frontal QRS-T angle is a strong predictor of the long-term risk of myocardial infarction and all-cause mortality in the diabetic populationJournal of Diabetes and its Complications, 2017
- Usefulness of Electrocardiographic Frontal QRS-T Angle to Predict Increased Morbidity and Mortality in Patients With Chronic Heart FailureThe American Journal of Cardiology, 2013
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression TrialThe American Journal of Cardiology, 1991
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984